Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Dronedarone successfully maintains sinus rhythm in patients with atrial fibrillation

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 641–642 (2007)Cite this article

Singh BN et al. (2007) Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 357: 987–999

Amiodarone is an effective antiarrhythmic agent, but it can have potentially serious adverse effects. Two identical multicenter trials were conducted to assess the efficacy of dronedarone, a potential alternative to amiodarone, for maintaining sinus rhythm in patients with atrial fibrillation (AF) or flutter. In total, 409 patients were randomized to placebo and 828 to dronedarone (400 mg orally twice daily). The mean age of participants was 63 years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dronedarone successfully maintains sinus rhythm in patients with atrial fibrillation. Nat Rev Cardiol 4, 641–642 (2007). https://doi.org/10.1038/ncpcardio1024

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1024

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing